Health

Brazil is experiencing a rise in mpox cases in 2026, with a current total of 81 confirmed infections, according to the Ministry of Health. While the majority of cases are mild to moderate, the increase prompts continued vigilance and monitoring from public health officials. The majority of those affected are adults, highlighting a key demographic in the current outbreak.

The largest concentration of cases is located in the state of São Paulo, accounting for 57 of the confirmed infections. Other affected states include Rio de Janeiro (13), Rondônia (4), Minas Gerais (3), Rio Grande do Sul (2), the Federal District (1), and Paraná (1). Health authorities are actively working with state epidemiological surveillance agencies to track the spread and implement appropriate control measures.

This uptick in mpox cases follows a more significant outbreak in 2025, where Brazil recorded 1,079 cases and, tragically, two deaths. The current situation, while concerning, is characterized by less severe illness, with no deaths reported so far this year. The Ministry of Health emphasizes that the Unified Health System (SUS) is prepared for early identification, clinical management, and patient follow-up.

Understanding Mpox: Symptoms and Transmission

Mpox, formerly known as monkeypox, is a viral disease caused by the MPXV virus, belonging to the Orthopoxvirus family. The infection typically begins with symptoms resembling other viral infections, such as fever, headache, and muscle pain. These initial symptoms are often followed by the development of characteristic skin lesions – blisters, sores, or crusts – that are a hallmark of the disease.

Key symptoms of mpox include:

• Fever
• Headache
• Muscle aches
• Fatigue or weakness
• Swollen lymph nodes (especially in the neck, armpits, or groin)
• Skin eruptions or lesions

Transmission of mpox can occur through close contact with an infected individual or with materials contaminated by the virus, such as clothing or bedding. Contact tracing for 14 days is being utilized to interrupt chains of transmission, as per Ministry of Health protocols. Individuals experiencing symptoms are advised to seek medical attention and practice social isolation while awaiting evaluation.

New Variants and Ongoing Monitoring

The World Health Organization (WHO) has confirmed the emergence of a new recombinant variant of mpox, prompting increased global vigilance. While this new variant is under close scrutiny, current data does not indicate that it causes more severe illness. However, continued monitoring is crucial to assess any potential changes in the virus’s behavior. As of February 18, 2026, 48 cases had been confirmed nationally, a figure that has since risen to 81, according to the Ministry of Health .

In São Paulo, the state health secretariat reports 44 confirmed cases this year, based on 185 notifications received. Of those notifications, 71 remain suspected, 57 have been ruled out, and one is classified as probable. The state health department affirms its commitment to continuous monitoring and coordination with municipal health departments.

What to Expect Moving Forward

Brazilian health authorities are maintaining active surveillance and emphasizing the importance of prevention, rapid diagnosis, and isolation as key strategies for controlling the spread of mpox. The SUS remains prepared to provide care and support to those affected. The situation is evolving, and ongoing monitoring will be essential to understand the trajectory of the outbreak and implement effective public health interventions.

Stay informed about mpox and consult with healthcare professionals if you experience any concerning symptoms. Sharing this information can help raise awareness and protect our communities.

Disclaimer: This article provides informational content about mpox and should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any health condition.

Seoul, South Korea – Dr. G, a dermocosmetic brand known for its science-backed skincare, has introduced its latest innovation: the ‘Skinboost PDRN Sun Serum.’ Launched on February 25, 2026, this new product goes beyond traditional sun protection, aiming to deliver deep hydration and strengthen the skin’s barrier function while shielding against UV damage. The launch reflects a growing understanding of the long-term effects of sun exposure on skin health, moving beyond simply preventing sunburn.

The development of the ‘Skinboost PDRN Sun Serum’ is rooted in the insights of Dr. An Gun-young, a dermatologist and the founder of Dr. G. Dr. An’s research highlights that UV damage isn’t merely a temporary issue, but a catalyst for photoaging – the long-term breakdown of collagen and moisture in the skin. This understanding has driven the creation of a sun serum designed to actively improve skin condition alongside providing UV protection. The product aims to address the increasing consumer demand for sun care that offers more than just SPF.

Key Ingredients and Technology

The ‘Skinboost PDRN Sun Serum’ features a synergistic blend of PDRN (Polydeoxyribonucleoside), collagen, and hyaluronic acid. These ingredients work together to provide a plumping effect, boosting hydration from within the skin. A core technology utilized in the serum is the ‘PDRN Barrier Film,’ which creates a transparent protective layer upon application, shielding the skin from UV rays and simultaneously aiding in the recovery of UV-damaged skin. According to the company, this technology is key to the serum’s ability to both protect and repair.

The serum’s texture is also a key differentiator. Formulated as a “real serum type” containing approximately 80% moisture serum, it incorporates UV capsules within the PDRN moisture serum. This allows for a lightweight, non-sticky application that absorbs quickly into the skin. The resulting finish is described as smooth and dewy, making it an ideal base for makeup – a feature often sought after by consumers, referred to as “hwajalmuk” (화잘먹) in Korean, meaning “makeup goes on well.”

Expanding the Definition of Sun Care

Dr. G is positioning the ‘Skinboost PDRN Sun Serum’ as a new category within sun care – “skinboost” – that focuses on proactively enhancing the skin’s natural condition. This approach aligns with the brand’s philosophy of prioritizing the skin’s inherent ability to heal and maintain health. Shin Yang-hee, Domestic Head of Goun Sesang Cosmetics, emphasized this commitment, stating that Dr. G continues to uphold the legacy of Dr. An Gun-young’s dedication to skin science and integrity. As reported by the Ilganbosa, Shin Yang-hee expressed hope that the new serum will develop into an essential part of daily skincare routines for everyone.

The serum’s formulation addresses concerns about the cumulative effects of UV exposure. ZDNet Korea reports that the product is designed to combat the long-term reduction of skin moisture and collagen caused by UV radiation. This focus on preventative skincare reflects a broader trend in the beauty industry towards products that offer both immediate protection and long-term benefits.

The launch of the ‘Skinboost PDRN Sun Serum’ signals a potential shift in the sun care market, with consumers increasingly seeking products that offer a holistic approach to skin health. The combination of UV protection with hydrating and barrier-strengthening ingredients positions Dr. G’s new serum as a contender in the evolving landscape of skincare.

Looking ahead, it will be significant to observe consumer response to this new category of “skinboost” sun care and whether other brands follow suit with similar formulations. The success of the ‘Skinboost PDRN Sun Serum’ could pave the way for a more comprehensive approach to sun protection, prioritizing not just shielding the skin from damage, but actively enhancing its resilience and overall health.

Have you tried sun serums before? Share your thoughts in the comments below!

Disclaimer: This article provides informational content about a skincare product and is not intended to be a substitute for professional medical advice. Always consult with a qualified healthcare provider for any questions you may have regarding your skin health.

Lafayette, Louisiana – A heartwarming reunion took place recently at Our Lady of Lourdes Heart Hospital, bringing together physicians and the patients whose lives they’ve touched. The event provided a space for gratitude, reflection and a celebration of advancements in cardiovascular care within the Acadiana region.

The reunion underscored the strong bonds formed between healthcare professionals and those they serve, particularly in the specialized field of cardiology. Our Lady of Lourdes Regional Medical Center and its Heart Hospital have earned national recognition for both the treatment of a wide range of heart conditions and a commitment to a positive patient experience, fostering a level of trust that extends far beyond medical procedures. Thousands of patients in the Acadiana area rely on the hospital for their cardiac health needs, and the reunion served as a testament to that confidence.

The event offered former patients a chance to express their thanks directly to the doctors, nurses, and staff who played a crucial role in their recovery and ongoing well-being. Heart disease remains a leading cause of death in the United States, affecting both men and women, but advancements in treatment and preventative care are continually improving outcomes. The hospital’s dedication to these advancements was a central theme of the gathering.

A Legacy of Cardiac Care in Lafayette

Our Lady of Lourdes has been a cornerstone of healthcare in Lafayette for decades. According to historical records, the hospital first opened its doors near the University of Louisiana at Lafayette campus on St. Mary Street in 1949. NewsBreak reports that Lafayette General, another prominent hospital in the area, has since become part of the Ochsner system in 2020.

Technological Advancements and Patient Outcomes

Recent investments in technology are further enhancing the quality of care at Our Lady of Lourdes Heart Hospital. In January 2026, the hospital opened a new Electrophysiology (EP) Lab, expanding access to advanced treatments for conditions like atrial fibrillation (AFib) and other heart rhythm disorders. USA Today reports this expansion is part of a larger $100 million investment initiative across all Our Lady of Lourdes campuses.

Judge Greg LeGros of Jeanerette, Louisiana, recently reunited with his care team at Our Lady of Lourdes after undergoing a life-altering heart procedure in November. LeGros received a transcatheter aortic valve replacement (TAVR), a minimally invasive procedure that avoids the need for traditional open-heart surgery. KATC reports that LeGros praised the quality of cardiac care available locally, noting his quick recovery and comfort following the procedure. His surgeon, Dr. Eric Thomassee, highlighted the rewarding nature of witnessing such positive patient outcomes.

The Importance of Preventative Care

While advancements in treatment are crucial, preventative measures remain paramount in the fight against heart disease. Maintaining a healthy lifestyle, including regular exercise, a balanced diet, and avoiding smoking, can significantly reduce the risk of developing cardiovascular problems. Regular check-ups with a healthcare provider are also essential for early detection and management of risk factors.

The patient reunion at Our Lady of Lourdes Heart Hospital serves as a powerful reminder of the human connection at the heart of healthcare. It’s a celebration of successful treatments, dedicated medical professionals, and the enduring spirit of those who have overcome cardiac challenges. The hospital’s continued investment in technology and commitment to patient care positions it as a vital resource for the Acadiana community.

Looking ahead, Our Lady of Lourdes Heart Hospital will continue to focus on delivering innovative cardiac care and expanding access to advanced treatments for patients throughout the region. Further developments in minimally invasive procedures and preventative cardiology are expected to improve outcomes and enhance the quality of life for individuals at risk of or living with heart disease.

Share your thoughts and experiences with cardiac care in the comments below. Let’s continue the conversation and support each other on the path to heart health.

Disclaimer: This article provides informational content and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.